MissionIR Articles
-
MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Invests C$2 Million in Dynaleo, Eyes Significant Opportunity in Cannabis Gummies Market
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced a C$2 million investment in Dynaleo Inc., an Edmonton-based company focused on white-label manufacturing of edible cannabis gummies for the…
-
MissionIRNewsBreaks – Canopy Rivers Inc.’s (TSX: RIV) (OTC: CNPOF) PharmHouse Increases Bank Debt Facility by $10M, Signifying Confidence in the Joint Venture
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its 49%-owned joint venture in Leamington, Ontario, PharmHouse Inc., amended its syndicated credit facility (“Credit Facility”) with the Bank…
-
MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Portfolio Company Obtains C$80.5M Debt Financing Arrangement with Canopy Growth Corp. (TSX: WEED) (NYSE: CGC)
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Wednesday announced that TerrAscend Canada Inc., a wholly owned subsidiary of CNPOF’s portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF), has…
-
MissionIRNewsBreaks – Canopy Rivers Inc.’s (TSX: RIV) (OTC: CNPOF) PharmHouse Receives Health Canada License Amendment for Cultivation Across Entire Greenhouse
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its 49%-owned joint venture in Leamington, Ontario, PharmHouse Inc., received a license amendment from Health Canada allowing for cultivation…
-
MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Reports Q3 Fiscal Year 2020 Financial Results, Provides Corporate Update
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today released its financial results for the three and nine months ended December 31, 2019. According to the update, the company’s unaudited…
-
MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Files Early Warning Report Regarding James E. Wagner Cultivation Corp. (TSX.V: JWCA) (OTCQX: JWCAF) Investment
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning announced that Canopy Rivers Corporation, a wholly owned subsidiary of the company, subscribed for 2,380,952 units of James E. Wagner…
-
MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Subsidiary Modifies TerrAscend Canada Loan Terms
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning announced that Canopy Rivers Corporation, a wholly-owned subsidiary of the company, has amended the terms of its recent US$10 million…
-
MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Provides Update on Portfolio Companies
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning provided an update regarding recent announcements from its portfolio companies High Beauty, Inc., TerrAscend Corp. (CSE: TER), YSS Corp. (TSX.V:…
-
MissionIRNewsBreaks – Canopy Rivers Inc.’s (TSX: RIV) (OTC: CNPOF) BioLumic Receives Approval to Apply Proprietary UV Light Technology to Medical Cannabis
Canopy Rivers (TSX: RIV) (OTC: CNPOF) portfolio company BioLumic Ltd. has received New Zealand Ministry of Health approval to apply its proprietary ultraviolet (“UV”) light technology to medical cannabis. According to the update, BioLumic’s approach…
-
MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Bolsters its Strategic Advisory Board with Kevin Durant’s Thirty Five Ventures
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced the expansion of its strategic advisory board to add Thirty Five Ventures, the business owned by NBA star Kevin Durant…
-
MissionIRNewsBreaks – Canopy Rivers Inc.’s (TSX: RIV) (OTC: CNPOF) Portfolio Companies Expand for Success in the Growing Market
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced the broadening of operations of its portfolio companies as they position for success in the growing market. The update highlighted…
-
MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Reports Q2 Fiscal Year 2020 Financial Results, Provides Corporate Update
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning released its financial results for the three and six months ended September 30, 2019. The company’s unaudited condensed interim consolidated…
-
MissionIRNewsBreaks – Canopy Rivers Inc.’s (TSX: RIV) (OTC: CNPOF) Radicle Medical Marijuana Awarded Health Canada Oil License
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning announced that its portfolio company, Radicle Medical Marijuana Inc., has received approval for oil sales from Health Canada. The additional…
-
MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) and Kindred Form Strategic Alliance to Unlock Industry’s Long-Term Potential
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, and Kindred Partners Inc., a specialty cannabis brokerage and services company, today announced a strategic alliance to provide mutual benefits to both…
-
MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) to Release Q2 Financial Results, Host Conference Call on November 14
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Monday announced that it will report its second quarter fiscal year 2020 financial results before markets open on Thursday, November 14,…
-
MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Portfolio Company Obtains Health Canada License Amendment
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Tuesday announced that its portfolio company James E. Wagner Cultivation Corp. (TSXV: JWCA) (OTCQX: JWCAF) (“JWC”) received a Health Canada license…
-
MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Portfolio Company Receives Health Canada Approval for Facility Expansion
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Monday announced that its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has gained Health Canada approval for a significant expansion…
-
MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Details Surrounding TerrAscend Canada Investment
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today provided details surrounding its investment in connection with a financing announced October 2, 2019. According to the update, Canopy Rivers has…
-
MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Additional $10M Investment in TerrAscend Canada Inc.
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced completion of a US$10 million investment in TerrAscend Canada Inc., a subsidiary of its portfolio company TerrAscend Corp. (CSE: TER)…
-
MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Portfolio Company Enters Distribution Agreement to Launch Medical Cannabis Inhaler in Canada
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has entered into a distribution agreement with Israel-based pharma-tech company…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Marks Pivotal Moment on Path to 2026 Rare Earth Oxide Production
- PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) Marks Bold Entry Into the Growing Battery Storage Market with 4.99 MW BESS in Ontario
- Soligenix Inc. (NASDAQ: SNGX) Working to Advance Heat-Stable Ricin Vaccine with Promising Efficacy
- New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Eyes Bolivia’s Untapped Silver Potential Amid Global Supply Gaps
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 2025 Results, Advances TPI 287 Toward Phase 2 GBM Trial